Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.24 USD | -2.43% | -0.54% | +16.08% |
Apr. 24 | Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Wednesday Amid Earnings Deluge | MT |
Apr. 24 | Centessa Pharmaceuticals Prices Equity Offering at $9.25 Per ADS | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.08% | 1.05B | |
+22.79% | 47.9B | |
+46.56% | 41.42B | |
-1.88% | 40.7B | |
-6.20% | 28.92B | |
+11.39% | 25.55B | |
-21.08% | 19.27B | |
-1.41% | 12.15B | |
+30.52% | 12.14B | |
-0.48% | 11.99B |
- Stock Market
- Equities
- CNTA Stock
- News Centessa Pharmaceuticals plc
- Centessa Pharmaceuticals Doses First Patient in Phase 3 Trial of Lixivaptan; Payment Triggered